More people are surviving cancer than ever before. But in Switzerland a historical diagnosis can follow former patients for years, especially when they try to take out income protection insurance. A campaign to allow a limited "Right to Be Forgotten" is trying to provide better financial security for thousands.
Cured but uninsurable: the hidden financial burden of surviving cancer in Switzerland
15 aprile 2026
Europe’s booming fertility industry has been rocked by revelations that the sperm of a Danish donor used to conceive at least 197 babies carried a cancer-causing genetic mutation that has already led to the deaths of some children. Switzerland’s strict regulations make scenarios of this scale unlikely.
When sperm crosses borders, national safeguards fall short
13 febbraio 2025
Cancer rates among adolescents and adults under 50 are rising globally, but many countries, including Switzerland, are struggling to deal with the challenges they pose, from preserving fertility to difficulties accessing financial services.
Under-50s cancer patients face system unprepared for them
17 novembre 2025
Outbreaks of vaccine-preventable diseases such as measles and whooping cough are making headlines once again – not only in countries with limited access to healthcare, but also in regions where inoculation is widely available and free.
Dealing with vaccine hesitancy in the age of misinformation – lessons from Switzerland
12 luglio 2025
Generic drugs run on thin margins and tight supply chains. Any disruption triggered by increased tariffs could raise prices, push some manufacturers out of the market and even worsen medicine shortages.
How US tariffs could disrupt the generic drugs supply chain
1 luglio 2025
Measles, a disease once close to eradication, is making a global comeback, with major outbreaks in the US and spikes across Europe. In Switzerland, a crisis is unlikely – but health authorities warn maintaining strong vaccination rates is crucial.
Global concern over measles is rising. Should Switzerland worry?
30 maggio 2025